Should Researchers Actively Look for Findings That Are Outside the Research Question?

If Researchers Would Act on a Finding, Should They Go Looking for It?

Imagine that a research team already has whole-genome sequence data from its participants. The investigators are studying one disease, but the same data could be analyzed for variants associated with other serious and potentially preventable conditions.

If researchers would feel obligated to respond if they happened to notice one of those variants, an uncomfortable question follows: why wait to stumble across it? Why not deliberately search?

This is sometimes called the duty to look or duty to hunt problem. It exposes an important difference between managing information produced by research and deliberately expanding research activities to generate additional information for participants.

There Is No General Duty to Search Beyond the Research Question

Finding Something and Searching for Something Are Different Ethical Acts

A duty to respond is not automatically a duty to search

Suppose a researcher examining an MRI for a neuroscience study notices an unexpected abnormality that might threaten the participant's health. There may be good ethical reasons to assess and appropriately respond to what has already come to light.

That does not necessarily mean the researcher must systematically inspect every image for every possible abnormality. The first situation concerns information encountered because of the research. The second expands the research team's activity into deliberate screening.

The distinction parallels the difference between incidental and secondary findings. Once researchers intentionally conduct an additional search outside the primary research purpose, the resulting information is better understood as a secondary finding under frameworks that distinguish the terms this way.

Why isn't the obligation automatic?

The primary social purpose of research is to generate generalizable knowledge, not to provide each participant with comprehensive diagnostic screening. Researchers certainly owe ethical duties to participants, but those duties do not ordinarily make the research team responsible for discovering every potentially useful fact that the available data might reveal.

Active searching can require additional analysis, specialist interpretation, confirmatory testing, counseling, recontact systems, secure long-term data management, referral pathways, and funding. It can also generate false positives, uncertain findings, anxiety, and downstream medical procedures.

Those consequences matter because the ethical question is not simply, “Could finding this information help someone?” It is also, “What must the research enterprise do to search for, validate, interpret, communicate, and support this information responsibly?”

There is no universal research obligation to search for secondary findings

Current NIH guidance for its Secondary Genomics Findings Service explicitly notes that there is no general or universal obligation for researchers to actively search for secondary findings. It also recognizes that obligations can be context-dependent. Within NIH's intramural research program, new protocols involving human genomic DNA sequencing are expected to describe a plan for returning clinically actionable secondary genomic findings unless there is a strong justification not to do so.

This illustrates why researchers should distinguish a universal ethical rule from an institution-specific policy. A particular research program or IRB may expect deliberate secondary analysis even though research ethics does not impose that requirement on every researcher using genomic data.

Clinical recommendations should not automatically be imported into research

Genomics provides a particularly instructive example. The American College of Medical Genetics and Genomics has developed recommendations for deliberately analyzing specified genes for medically actionable secondary findings in clinical exome and genome sequencing. The current ACMG secondary-findings framework concerns clinical genomic testing.

NHGRI has specifically noted that ACMG recommendations to deliberately search for certain variants were developed for clinical encounters rather than as a general requirement for research. Some researchers and institutions have nevertheless adopted related approaches in research settings.

Research can resemble clinical care to different degrees. A longitudinal clinical study with continuing participant contact and specialist infrastructure presents a different situation from analysis of coded genomic data obtained from a repository with no practical route for recontact. The existence of the same sequence data does not erase those differences.

There is a serious ethical argument for a limited duty to look

The absence of a general duty does not end the debate. Bioethicists have argued that researchers may sometimes acquire a moral obligation to search for secondary findings when doing so resembles an “easy rescue”: the expected benefit to participants is large while the cost and burden of finding the information are sufficiently small.

On this reasoning, imagine that a validated analysis could identify a small set of highly actionable, life-threatening conditions with little additional effort or cost. If identifying those conditions could prevent substantial harm, the distinction between accidentally encountering the information and deliberately searching for it becomes ethically harder to defend.

Published scholarship has therefore argued that a duty to search could emerge as genomic interpretation becomes more reliable, benefits become clearer, and the burden of additional analysis falls. This remains an ethical argument rather than a universal research requirement, but it identifies an important point: what counts as an unreasonable additional burden can change with technology.

The expected benefit has to include more than the possibility of finding something

Searching is easier to justify when the targeted findings have strong analytic validity, substantial clinical importance, and meaningful actionability. The case weakens when interpretation is uncertain, penetrance is poorly understood, interventions are unavailable, or the search is likely to produce large numbers of ambiguous results.

The relevant comparison is therefore not “information versus no information.” It is the expected benefit of a carefully defined search weighed against the full costs and risks of generating and acting on its results.

Consent matters before the search begins

Deliberately searching for unrelated information can generate information participants did not expect to receive and may not want to know. Researchers should therefore address foreseeable secondary analyses during protocol development and informed consent rather than treating disclosure preferences as an afterthought.

The Presidential Commission recommended that researchers communicate the scope of potential incidental and secondary findings, whether they will be disclosed, how disclosure will occur, and whether participants may opt out of receiving certain findings. The more deliberate the search, the stronger the reason to make its purpose and consequences transparent in advance.

Participant choice about whether to receive individual findings and the corresponding right not to know potentially important information require their own analysis.

Researchers should not quietly expand the study after data collection begins

A researcher who realizes that an existing dataset could reveal medically valuable secondary information should not simply add a screening program informally. Deliberate secondary analysis can alter the study's ethical and operational commitments.

The proposed search may need ethics committee or IRB review, amendments to the protocol or consent process, a validation plan, specialist involvement, procedures for recontact and disclosure, and decisions about who bears the cost of confirmation and follow-up.

A Genome Contains Far More Information Than the Study Needs

Now change one feature of the scenario. Suppose a validated secondary analysis becomes nearly automatic, inexpensive, highly accurate, and capable of identifying conditions for which timely intervention prevents serious harm. The ethical argument for actively searching becomes stronger. This is why the duty-to-look debate cannot be settled solely by saying that secondary findings fall outside the original research question.

Common Mistakes About the Duty to Look

Treat Active Searching as a Study-Design Decision

If you are considering deliberately looking beyond your research question, do not frame the decision as merely checking data you already possess. You are proposing an additional analytic activity that can create new responsibilities toward participants.

The practical lesson is not “never look.” It is that looking should be intentional, justified, reviewed, and supported. Researchers should know before initiating the search what they will do if it succeeds.

Before Searching Beyond the Research Question

Questions About Searching for Findings Outside the Study

A Duty to Notice Is Not Automatically a Duty to Hunt

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.